In the adjusted model, cTnT was found to be positively associated with pre-clinical cardiovascular injury in NSCLC patients (OR: 1.791 × 1088; 95% CI: 6.706 × 1027–4.785 × 10148), while TGF-β1 (OR: 1.004; 95% CI: 1.0011–1.008) was slightly positively related to pre-clinical cardiovascular injury. The gene discussed is TGFB1; the disease is non-small cell lung carcinoma.